[{"Assets_0_Q2_USD":"11230300000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q2_USD":"0.24","CommonStockSharesIssued_0_Q2_shares":"133600000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.43","EarningsPerShareBasic_2_Q2_USD":"-0.15","EarningsPerShareDiluted_1_Q2_USD":"-0.43","EarningsPerShareDiluted_2_Q2_USD":"-0.15","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-82100000.0","NetIncomeLoss_1_Q2_USD":"-57700000.0","NetIncomeLoss_2_Q2_USD":"-19600000.0","OfficialName":"Perrigo Company plc Ordinary Shares","PaymentsOfDividends_2_Q2_USD":"65100000.0","RevenuesConverted_1_Q2_USD":"981100000.0","RevenuesConverted_2_Q2_USD":"1991100000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"5511100000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"133600000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"133400000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"133600000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"133400000.0","filed":"20210811","footnote":null,"form":"10-Q","fp":"Q2","fy":"2021.0","name":"PERRIGO CO PLC","period":"20210630","qtrs":"0","uom":"USD"}]